Literature DB >> 11441068

Expansion of the antigenic repertoire of a single T cell receptor upon T cell activation.

A Amrani1, P Serra, J Yamanouchi, J D Trudeau, R Tan, J F Elliott, P Santamaria.   

Abstract

Activated T cells and their naive precursors display different functional avidities for peptide/MHC, but are thought to have identical antigenic repertoires. We show that, following activation with a cognate mimotope (NRP), diabetogenic CD8(+) T cells expressing a single TCR (8.3) respond vigorously to numerous peptide analogs of NRP that were unable to elicit any responses from naive 8.3-CD8(+) T cells, even at high concentrations. The NRP-reactive, in vivo activated CD8(+) cells arising in pancreatic islets of nonobese diabetic mice are similarly promiscuous for peptide/MHC, and paradoxically this promiscuity expands as the aviditiy of the T cell population for NRP/MHC increases with age. Thus, activation and avidity maturation of T lymphocyte populations can lead to dramatic expansions in the range of peptides that elicit functional T cell responses.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11441068     DOI: 10.4049/jimmunol.167.2.655

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  22 in total

1.  Prediction of spontaneous autoimmune diabetes in NOD mice by quantification of autoreactive T cells in peripheral blood.

Authors:  Jacqueline D Trudeau; Carolyn Kelly-Smith; C Bruce Verchere; John F Elliott; Jan P Dutz; Diane T Finegood; Pere Santamaria; Rusung Tan
Journal:  J Clin Invest       Date:  2003-01       Impact factor: 14.808

2.  Enumerating autoreactive T cells in peripheral blood: a big step in diabetes prediction.

Authors:  George S Eisenbarth; Brian L Kotzin
Journal:  J Clin Invest       Date:  2003-01       Impact factor: 14.808

3.  A pancreatic beta-cell-specific homolog of glucose-6-phosphatase emerges as a major target of cell-mediated autoimmunity in diabetes.

Authors:  John C Hutton; George S Eisenbarth
Journal:  Proc Natl Acad Sci U S A       Date:  2003-07-14       Impact factor: 11.205

Review 4.  Effector lymphocytes in islet cell autoimmunity.

Authors:  Pere Santamaria
Journal:  Rev Endocr Metab Disord       Date:  2003-09       Impact factor: 6.514

5.  The pathogenicity of self-antigen decreases at high levels of autoantigenicity: a computational approach.

Authors:  Anmar Khadra; Pere Santamaria; Leah Edelstein-Keshet
Journal:  Int Immunol       Date:  2010-05-24       Impact factor: 4.823

6.  DEC-205-mediated antigen targeting to steady-state dendritic cells induces deletion of diabetogenic CD8⁺ T cells independently of PD-1 and PD-L1.

Authors:  Gayatri Mukherjee; Ari Geliebter; Jeffrey Babad; Pere Santamaria; David V Serreze; Gordon J Freeman; Kristin V Tarbell; Arlene Sharpe; Teresa P DiLorenzo
Journal:  Int Immunol       Date:  2013-09-10       Impact factor: 4.823

7.  Compensatory mechanisms allow undersized anchor-deficient class I MHC ligands to mediate pathogenic autoreactive T cell responses.

Authors:  Deanna Lamont; Gayatri Mukherjee; P Rajesh Kumar; Dibyendu Samanta; Caroline G McPhee; Thomas W H Kay; Steven C Almo; Teresa P DiLorenzo; David V Serreze
Journal:  J Immunol       Date:  2014-07-25       Impact factor: 5.422

8.  Islet lymphocyte subsets in male and female NOD mice are qualitatively similar but quantitatively distinct.

Authors:  Ellen F Young; Paul R Hess; Larry W Arnold; Roland Tisch; Jeffrey A Frelinger
Journal:  Autoimmunity       Date:  2009       Impact factor: 2.815

9.  Theranostic magnetic resonance imaging of type 1 diabetes and pancreatic islet transplantation.

Authors:  Ping Wang; Anna Moore
Journal:  Quant Imaging Med Surg       Date:  2012-09

10.  The proline-rich sequence of CD3epsilon as an amplifier of low-avidity TCR signaling.

Authors:  Pankaj Tailor; Sue Tsai; Afshin Shameli; Pau Serra; Jinguo Wang; Stephen Robbins; Masao Nagata; Andrea L Szymczak-Workman; Dario A A Vignali; Pere Santamaria
Journal:  J Immunol       Date:  2008-07-01       Impact factor: 5.422

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.